openPR Logo
Press release

What's driving the Traveler’s Diarrhea Therapeutics Market trends? Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron

06-12-2019 08:08 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: marketstudyreport.com

/ PR Agency: Market Study Report LLC
What's driving the Traveler’s Diarrhea Therapeutics Market trends? Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron

Market Study Report Has Added A New Report On Traveler’s Diarrhea Therapeutics Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market Size. Comprising The Current And Future Trends Defining The Dynamics Of This Industry Vertical, This Report Also Incorporates The Regional Landscape Of Traveler’s Diarrhea Therapeutics Market In Tandem With Its Competitive Terrain.

According to this study, over the next five years the Traveler's Diarrhea Therapeutics market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 890 million by 2024, from US$ 630 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Traveler's Diarrhea Therapeutics business.

Request a sample of this premium report titled Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024 at: www.marketstudyreport.com/request-a-sample/1503418?utm_so...

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.

Travelers diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey.

The classification of Travelers Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.

This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study considers the Traveler's Diarrhea Therapeutics value and volume generated from the sales of the following segments:

Segmentation by product type:
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other

Segmentation by application:
Adult Traveler's Diarrhea
Children Traveler's Diarrhea

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives:

To study and analyze the global Traveler's Diarrhea Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Traveler's Diarrhea Therapeutics market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Traveler's Diarrhea Therapeutics submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Focuses on the key global Traveler's Diarrhea Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Traveler's Diarrhea Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

Request a discount on standard prices of this premium report titled Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024 at: www.marketstudyreport.com/check-for-discount/1503418?utm_...

Table of Contents:

2019-2024 Global Traveler's Diarrhea Therapeutics Consumption Market Report

1 Scope of the Report

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Consumption 2014-2024
2.1.2 Traveler's Diarrhea Therapeutics Consumption CAGR by Region

2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Other
2.3 Traveler's Diarrhea Therapeutics Consumption by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2014-2019)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2014-2019)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2014-2019)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Consumption by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2014-2019)
2.5.2 Global Traveler's Diarrhea Therapeutics Value and Market Share by Application (2014-2019)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2014-2019)

3 Global Traveler's Diarrhea Therapeutics by Players

3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Players

3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Players (2017-2019)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Players (2017-2019)
3.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Players
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Players (2017-2019)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Players (2017-2019)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Players
3.4 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Traveler's Diarrhea Therapeutics by Regions

4.1 Traveler's Diarrhea Therapeutics by Regions
4.1.1 Global Traveler's Diarrhea Therapeutics Consumption by Regions
4.1.2 Global Traveler's Diarrhea Therapeutics Value by Regions
4.2 Americas Traveler's Diarrhea Therapeutics Consumption Growth
4.3 APAC Traveler's Diarrhea Therapeutics Consumption Growth
4.4 Europe Traveler's Diarrhea Therapeutics Consumption Growth
4.5 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Growth

Complete report titled at: www.marketstudyreport.com/reports/global-traveler-s-diarr...

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: www.marketstudyreport.com

Blog: www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Traveler’s Diarrhea Therapeutics Market trends? Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron here

News-ID: 1773556 • Views: 226

More Releases from marketstudyreport.com

What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Market Study Report LLC presents latest report on global Electric Vehicles Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2019-2026. The global electric vehicles market is anticipated to reach USD 912 billion by 2026 according to a new study. Electric vehicles are one of the
What are the Growth Drivers of Marine Lubricants Market? Synforce Lubricants, Va …
This Global Marine Lubricants market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years. Germany marine lubricants market from recreational ships should witness consumption of over 18 kilo tons at the end of 2024. Recreational boating activities include campaigning, sailing, fishing, water sport games and boat racing. Economic
Fitness Equipment Market Brief Analysis By Top Key Players | Amer Sports Corpora …
MarketStudyReport.com Adds New Fitness Equipment Market 2018 – 2024 research report providing information and data By Equipment, By End-Use Industry Analysis, Regional Outlook, Application Potential, Trends, Competitive Market Share & Forecast spreading across 452 Pages with table and figures in it. Fitness Equipment Market is expected to exceed USD 14 billion by 2024. Rising health awareness among people of all age groups is expected to accelerate the fitness equipment market growth.
What's driving the Embedded Software Market growth? Key Players are: ENEA, Green …
The Embedded Software market is expected to surpass USD 20 billion by 2025. The major market drivers are a rise in the IoT adoption, increase in governments? support for digitalization, and advancements in artificial intelligence & machine learning technologies. The increase in the demand for embedded OS in the automotive sector for enhanced in-vehicle infotainment systems, such as navigation, adaptive cruise control, parking assistance, and airbag, is also supporting the

All 18021 Releases


More Releases for Traveler Diarrhea Therapeutics

What's driving the Traveler’s Diarrhea Therapeutics Market trends? Salix Pharm …
Market Study Report Has Added A New Report On Traveler’s Diarrhea Therapeutics Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market Size. Comprising The Current And Future Trends Defining The Dynamics Of This Industry Vertical, This Report Also Incorporates The Regional Landscape Of Traveler’s Diarrhea Therapeutics Market In Tandem With Its Competitive Terrain. According to this study, over the next five years
Global Traveler's Diarrhea Therapeutics Market Report 2019 Companies included GS …
Market Reports Company has recently published 7th edition of Traveler's Diarrhea Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Traveler's Diarrhea Therapeutics market was valued at
Global Traveler's Diarrhea Therapeutics Market Expected to Witness a Sustainable …
New report published by Market Research Report Store (MRRS) which offers insights on the global Traveler's Diarrhea Therapeutics market. Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four
Carcinoid Syndrome Diarrhea Treatment Market
Carcinoid syndrome is caused by secretion of certain harmful chemicals by carcinoid tumors. Carcinoid syndrome may occur due to infection or other related diseases, and medical or surgical treatments such as anesthesia, chemotherapy, embolization, and tumor debulking. The key symptoms of the syndrome include flushing of the skin and diarrhea, rapid heartbeat, and bronchoconstriction. If remained undiagnosed, it could lead to several complications such as weight loss, electrolyte imbalance, dehydrations,